ChatGPTを活用して業務のAI化を進めています。プロンプトエンジニアリングの専門家です！と、名乗れるレベルではありませんが、かなり色々使いこなしてきています。この１年、病気で失われた能力は、別な能力を発達させる、進化することで生き残っていこうと思います。
<><><>
24/03/02
[HTML] Association between body fat decrease during the first year after diagnosis and the prognosis of idiopathic pulmonary fibrosis: CT-based body composition analysis
JY Lee, SH Yoon, JM Goo, J Park, JH Lee - Respiratory Research, 2024
… idiopathic pulmonary fibrosis (IPF) remains underexplored. We investigated the association between changes in body fat during the first year post-diagnosis and outcomes in patients with IPF. … Idiopathic pulmonary fibrosis (IPF) is a chronic …
- 診断後1年間の体脂肪減少と特発性肺線維症の予後との関連：CTに基づく体組成分析
High Dose Inhaled Corticosteroid Increased the Incidence of Idiopathic Pulmonary Fibrosis: Nationwide Population based Study
H Lee, H Yoon - 2024
… Idiopathic pulmonary fibrosis (IPF) is a progressive disease found primarily in older people, with the use of systemic steroids linked to poor … (ICS) in IPF remains unclear. This This study investigated the association between ICS use and IPF risk …
- 高用量の吸入コルチコステロイドは特発性肺線維症の発生率を増加させた：全国的な人口ベースの研究
[PDF] Hospitalizations as Clinical Trials Endpoint in ILD: Are We There Yet?
G Sgalla, E Bargagli - American Journal of Respiratory and Critical Care …, 2024
… Nevertheless, diverse hospitalization rates of IPF have been reported in the literature, and … , leveraging the opportunity presented by the Pulmonary Fibrosis Foundation (PFF) Patient Registry, … into distinct ILD subtypes, including IPF, non-IPF …
- ILDにおける臨床試験のエンドポイントとしての入院：まだそこにあるのか？
Respiratory Diseases Associated with Organic Dust Exposure
JA Poole, JL Zamora-Sifuentes, L De Las Vecillas… - The Journal of Allergy and …, 2024
… Organic dust exposures are linked to development of chronic bronchitis, 49 chronic obstructive pulmonary disease (COPD), asthma, asthma-like syndrome, byssinosis, 50 hypersensitivity pneumonitis (HP), and idiopathic pulmonary fibrosis (IPF) …
- 有機粉塵への曝露に関連する呼吸器疾患
[HTML] Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study
S Mori, Y Ueki, M Hasegawa, K Nakamura… - Plos one, 2024
… and idiopathic CPFE has also been suggested. According to recent meta-analyses, the risk of lung cancer in patients with idiopathicCPFE was significantly higher than that in patients with IPF or emphysema alone, and survival in lung cancer patients …
First ever characterisation of the effects of short telomeres in a Singapore interstitial lung disease cohort
MLW Kam, ST Chong, SH Chan, JJ Swigris, EL Chew… - Respiratory Investigation, 2024
… Interstitial Lung Disease (ILD) is an incurable group of lung diseases with varying extents of inflammation and fibrosis, of which idiopathicpulmonary fibrosis (IPF) has the poorest prognosis with a median survival of three to five years [1,2]. Telomeres …
[PDF] Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2
Y Yang, X Wang, J Zhang - Journal of Thoracic Disease, 2024
… Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis(IPF). These two drugs can slow the progression of … Idiopathic pulmonary fibrosis (IPF) is the most common type of interstitial lung disease (ILD). IPF is most …
- ピルフェニドンとニンテダニブはJAK2の発現を阻害することでマウスの肺線維症を軽減する
The clinical frailty scale for risk stratification in patients with fibrotic interstitial lung disease
SA Guler, DC Marinescu, G Cox, C Durand, JH Fisher… - CHEST, 2024
… In IPF mean annual FVC %-predicted decline was significantly larger in … relatively small effect size of DLCO decline in patients with non-IPF ILD. The larger decline in … characteristics and comorbidities in the CAnadian REgistry for …
- 線維性間質性肺疾患患者のリスク層別化のための臨床虚弱スケール
<>
24/02/29
[HTML] Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
A Zinellu, S Zoroddu, S Fois, S Mellino, C Scala… - Antioxidants, 2024
… for idiopathic pulmonary fibrosis (IPF). Our aim was to assess the prognostic potential of ischemia-modified albumin (IMA), an established circulating marker of ischemia and, more recently, oxidative stress, in a cohort of 56 IPF … associated …
[HTML] Psoriasis may increase the risk of idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study
L Chen, Y Wei, M Hu, Y Liu, X Zheng - Respiratory Research, 2024
… Although some studies have indicated that Psoriasis could contribute to the risk of idiopathic pulmonary fibrosis (IPF), no study has reported a clear causal association between them. Our aim was to explore the potential relationship between Psoriasis …
- 乾癬は特発性肺線維症のリスクを高める可能性がある：2サンプルのメンデルランダム化研究
<>
24/02/27
[PDF] Localized Administration of Bcar3 siRNA via Nano-Self-Assembly to Treat Idiopathic Pulmonary Fibrosis by Disrupting Macrophage-Fibroblast Crosstalk
C Zeng, Q Wang, X Liu, K Wang, C Wang, X Ju… - International Journal of …, 2024
Background Idiopathic pulmonary fibrosis(IPF) is a severe interstitial lung disease characterized by chronic lung injury leading to macrophage infiltration and fibroblast activation. However, there is no effective therapeutic strategy targeting the crucial …
- マクロファージと線維芽細胞のクロストークを破壊することにより特発性肺線維症を治療するためのナノ自己集合を介した Bcar3 siRNA の局所投与
[PDF] Two cases of idiopathic pulmonary fibrosis evaluated by dynamic digital radiography for diaphragmatic motion and disease progression
T Nikaido, Y Tanino, Y Sato, R Togawa, T Kawamata… - Respirology Case Reports, 2024
… Forced vital capacity has been utilized as a parameter of disease progression in idiopathicpulmonary fibrosis (IPF); however, its measurement is … two cases that suggest parameters obtained from DDR during supine normal tidal breathing may …
- ダイナミックデジタルX線撮影で横隔膜の動きと病気の進行を評価した特発性肺線維症の2例
[HTML] Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
J Ma, G Li, H Wang, C Mo - Biomedicine & Pharmacotherapy, 2024
… idiopathic pulmonary fibrosis (IPF), which is the most common form of pulmonaryfibrosis, is generally poor. The median survival for patients with IPF … This review aims to provide an updated overview of current and future drug interventions for …
- 抗肺線維症特性を持つ潜在的な薬剤の包括的なレビュー
Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic …
M Imai, H Okabayashi, K Akaike, S Hamada… - Respiratory Investigation, 2024
… It has also been approved for the treatment of idiopathic pulmonary fibrosis (IPF) and … with IPF, eight with unclassifiable idiopathicinterstitial pneumonia, five with fibrosing nonspecific interstitial pneumonia, two with desquamative interstitial …
[HTML] Demethyleneberberine Alleviates Pulmonary Fibrosis through Disruption of USP11 Deubiquitinating GREM1
C Ge, M Huang, Y Han, C Shou, D Li, Y Zhang - Pharmaceuticals, 2024
… Idiopathic pulmonary fibrosis (IPF) is a fatal and chronic interstitial lung disease in which myofibroblast foci formation and massive amount of extracellular matrix (ECM) components’ deposition eventually leads to the destruction of lung function [1,2]. The …
- デメチレンベルベリンはGREM1を脱ユビキチン化するUSP11の破壊を通じて肺線維症を軽減
[HTML] Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
CW Huang, SY Lee, CX Du, ST Wu, YH Kuo, HC Ku - Biomedicine & …, 2024
… Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease; its cause is unknown, and it leads to notable … nor stabilize IPF or the symptoms perceived by patients. Therefore, the development of novel treatment …
- カフェ酸エタノールアミドは、抗線維症、抗炎症、抗酸化作用を誘発し、ブレオマイシン誘発性肺線維症を防ぎます。
Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort …
N Enomoto, S Yazawa, Y Mochizuka, A Fukada… - Respiratory Medicine, 2024
… CTD-ILD is the most important differential diagnosis of idiopathic interstitial pneumonias (IIPs) with a focus on idiopathic pulmonaryfibrosis (IPF). The most important differences between CTD-ILD and IPF are the response to …
[HTML] Examining the incidence of interstitial lung disease subtypes in South America
K Nesset, M Kolb - Jornal Brasileiro de Pneumologia, 2024
… disease, familial pulmonary fibrosis, or idiopathic interstitial pneumonias. The latter group includes idiopathic pulmonary fibrosis(IPF), which … While many of the previous epidemiologic studies have primarily focused on IPF, regional variability in …
- 南米における間質性肺炎のサブタイプの発生率を調べる
Interstitial lung disease in autoimmune diseases
V Nagaraja, I Mira-Avendano, A Diaz-Arumir, M Gotway… - Revista Colombiana de …, 2024
… Although some are idiopathic (eg, idiopathicpulmonary fibrosis, idiopathic interstitial pneumonias [IIP] and sarcoidosis), the great majority have an underlying etiology, such as connective tissue diseases (CTD), inhalational exposure to organic …
- 自己免疫疾患における間質性肺疾患
Epidemiology and Risk Factor for Interstitial Lung Diseases
N Jeganathan, T Corte, P Spagnolo - Frontiers in Medicine
… Their meta-analysis demonstrates a significant association between acute exacerbation of idiopathic pulmonary fibrosis(IPF) and … real-world clinical experience of IPFby reporting data from a 15-year period. Analyzing a cohort of 634 …
- 間質性肺疾患の疫学と危険因子
<><><>
特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。
当面、毎週アラートの内容をアップしていこうと思います。
###
